* Inari Medical Inc NARI.OQ reported quarterly adjusted
earnings
of 5 cents per share for the quarter ended in September,
higher than the same quarter last year, when the company
reported EPS of -19 cents. The mean expectation of
nine analysts for the quarter was for breakeven results per
share. Wall Street expected results to range from -7 cents to 5
cents per share.
* Revenue rose 31.4% to $126.37 million from a year ago;
analysts
expected $121.92 million.
* Inari Medical Inc's reported EPS for the quarter was 5
cents.
* The company reported quarterly net income of $3.16
million.
* Inari Medical Inc shares had fallen by 7.2% this
quarter and
lost 4.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Inari Medical Inc
is $84.50
This summary was machine generated from LSEG data November 2 at
01:35 a.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 0.00 0.05 Beat
Jun. 30 2023 -0.13 0.04 Beat
Mar. 31 2023 -0.23 -0.04 Beat
Dec. 31 2022 -0.17 -0.11 Beat